MANNKIND CORP Interest Payable
MANNKIND CORP (MNKD) had Interest Payable of $2.00 million as of 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2014-08-11
- 2014-06-30: Interest Payable $2.00M.
- 2014-03-31: Interest Payable $1.30M.
| Period end | Interest Payable |
|---|---|
| 2014-06-30 | $2.00M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.30M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |